---
schema_version: "secwatch.filing_event.v1"
accession: "0001708599-25-000005"
form_type: "8-K"
ticker: "SER"
cik: "0001708599"
company_name: "Serina Therapeutics, Inc."
filed_at: "2025-01-15T23:59:59+00:00"
generated_at: "2026-05-28T01:12:54.292143+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Serina Therapeutics appoints Karen J. Wilson to board; Steven Mintz departs

## Summary
- Karen J. Wilson appointed effective Jan 14, 2025; over 30 years life sciences finance experience, CPA.
- Wilson will serve as Compensation Committee Chair and on the Audit Committee.
- Steven Mintz departs board; no disagreement; Remy Gross replaces as Audit Committee chair.
- Wilson also serves on boards of Connect Biopharma, Elicio Therapeutics, and LAVA Therapeutics.

## SEC filing metadata
- accession: 0001708599-25-000005
- form_type: 8-K
- ticker: SER
- cik: 0001708599
- company_name: Serina Therapeutics, Inc.
- filed_at: 2025-01-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1708599/000170859925000005/0001708599-25-000005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1708599/000170859925000005/ser-20250114.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001708599-25-000005
- JSON: https://secwatch.observer/filing/0001708599-25-000005.json
- Plain text: https://secwatch.observer/filing/0001708599-25-000005.txt

## Key facts
- Executive change
  Steven Mintz departed as Director at Serina Therapeutics, Inc..
  - Action: departed
  - Role: Director
  source text: departure of Steven Mintz from its Board of Directors
  evidence_url: https://www.sec.gov/Archives/edgar/data/1708599/000170859925000005/0001708599-25-000005-index.htm
- Executive change
  Karen J. Wilson was appointed as Director at Serina Therapeutics, Inc..
  - Action: appointed
  - Role: Director
  source text: appointment of Karen J. Wilson to the Company’s Board of Directors, effective January 14, 2025
  evidence_url: https://www.sec.gov/Archives/edgar/data/1708599/000170859925000005/0001708599-25-000005-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.